By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > Drugs A-Z > Statin > Rosuvastatin

Rosuvastatin

GMJ
Last updated: 01/06/2026 20:19
By
GMJ News Desk
Share
5 Min Read
SHARE
3 min read|632 words

Rosuvastatin Drug Profile

What is Rosuvastatin?

Rosuvastatin is a prescription medication belonging to a class of drugs called statins, specifically HMG-CoA reductase inhibitors. It is primarily used to lower cholesterol levels and reduce the risk of cardiovascular disease in patients with elevated blood cholesterol. This medication is considered one of the most potent statins available for managing dyslipidemia.

Uses

Rosuvastatin is prescribed for several cardiovascular-related conditions:

  • High cholesterol (hypercholesterolemia): Reduces LDL (“bad”) cholesterol and total cholesterol levels in patients with primary hyperlipidemia
  • Mixed dyslipidemia: Treats patients with elevated cholesterol and triglyceride levels while helping to increase HDL (“good”) cholesterol
  • Cardiovascular disease prevention: Reduces the risk of heart attack, stroke, and other cardiovascular events in patients with risk factors
  • Familial hypercholesterolemia: Manages inherited conditions causing extremely high cholesterol levels, including homozygous and heterozygous familial hypercholesterolemia
  • Hypertriglyceridemia: Helps lower elevated triglyceride levels when used as part of comprehensive lipid management

How it works

Rosuvastatin works by blocking HMG-CoA reductase, an enzyme that plays a crucial role in cholesterol production in the liver. By inhibiting this enzyme, the medication reduces the liver’s ability to manufacture cholesterol, forcing the body to remove existing cholesterol from the bloodstream. This mechanism effectively lowers total cholesterol, LDL cholesterol, and triglycerides while modestly increasing beneficial HDL cholesterol levels.

Side effects

Common side effects include:

Submit Your Paper
GMJ_Submit_Banner
  • Headache
  • Muscle pain or weakness (myalgia)
  • Abdominal pain
  • Nausea
  • Dizziness
  • Constipation
  • Fatigue
  • Upper respiratory tract infections

Serious side effects requiring immediate medical attention:

  • Severe muscle pain, tenderness, or weakness (possible rhabdomyolysis)
  • Dark-colored urine or decreased urination
  • Unexplained fatigue or fever
  • Yellowing of skin or eyes (jaundice)
  • Severe abdominal pain

Warnings and precautions

  • Liver disease: Patients with active liver disease or unexplained elevated liver enzymes should not use rosuvastatin, as it may worsen liver function
  • Pregnancy and breastfeeding: Rosuvastatin is contraindicated during pregnancy and breastfeeding due to potential harm to the developing fetus or nursing infant
  • Kidney impairment: Patients with severe kidney disease require dose adjustments, as the medication can accumulate and increase the risk of side effects
  • Muscle disorders: Individuals with a history of muscle diseases or previous statin-related muscle problems should be monitored closely for signs of muscle toxicity
  • Asian ancestry: Patients of Asian descent may require lower starting doses due to increased drug exposure and higher risk of side effects

Interactions

  • Warfarin: May increase bleeding risk by enhancing warfarin’s anticoagulant effects, requiring more frequent INR monitoring
  • Cyclosporine: Significantly increases rosuvastatin levels, potentially leading to severe muscle toxicity and requiring dose reduction
  • Gemfibrozil: Increases rosuvastatin concentration and muscle toxicity risk when used together for lipid management
  • Antacids containing aluminum or magnesium: Reduce rosuvastatin absorption when taken simultaneously; separate doses by at least 2 hours
  • Lopinavir/ritonavir: HIV protease inhibitors that increase rosuvastatin levels and potential side effects
  • Fenofibrate: May increase muscle toxicity risk when combined with rosuvastatin for treating mixed dyslipidemia
  • Niacin (high doses): Combination therapy may increase the risk of muscle-related side effects
  • Red yeast rice supplements: Contains natural statins that may compound effects and increase side effect risk

Check interactions with the GMJ Interaction Checker

Dosage

Adult dosing typically ranges from 5 mg to 40 mg taken once daily, usually in the evening. Most patients start with 10-20 mg daily, with dose adjustments made every 2-4 weeks based on cholesterol levels and individual response. Patients with kidney impairment or those of Asian ancestry often require lower starting doses of 5 mg daily. The maximum recommended dose is 40 mg daily, reserved for patients who have not achieved target cholesterol levels with lower doses. All dosing decisions should be individualized and determined by a healthcare provider based on patient-specific factors and treatment goals.

Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.

Cite this page

GMJ News Desk. "Rosuvastatin." GMJ News — Georgian Medical Journal, 1 June 2026. https://news.gmj.ge/drug/rosuvastatin/

CC BY 4.0This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).

Was this article helpful?

Share This Article
Facebook LinkedIn Bluesky Copy Link Print

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
Endometriosis Affects 10% of Women Yet Faces Chronic Under-recognition, BBC Investigation Reveals

BBC investigation reveals endometriosis affects 10% of women yet faces chronic under-recognition,…

Medical School Diversity Gains Not Translating to Diverse Physician Workforce

Despite medical schools successfully diversifying enrollment, these gains aren't translating to physician…

Maternity Staff Used Offensive Terms for Patients, BBC Investigation Reveals

BBC Panorama investigation reveals maternity staff at Nottingham University Hospitals NHS Trust…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Pravastatin

By
GMJ News Desk
01/06/2026

Fluvastatin

By
GMJ News Desk
01/06/2026

Pitavastatin

By
GMJ News Desk
01/06/2026

Pitavastatin

By
GMJ News Desk
01/06/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up